In a significant move to strengthen Indonesia’s healthcare infrastructure, PT Kalbe Farma Tbk (Kalbe) and GE HealthCare have officially inaugurated the country’s first production facility dedicated to manufacturing technologically advanced CT (Computed Tomography) scanners. Located at PT Forsta Kalmedic Global (Forsta) in Bogor. The facility is a milestone in localizing advanced medical device production and enhancing diagnostic capabilities across the nation.
The launch ceremony was attended by Indonesia’s Director General Pharmaceutical and Medical Device, Ministry of Health, Lucia Rizka Andalusia and Deputy for Licensing and Inspection from the Nuclear Energy Regulatory Agency, Zainal Arifin, together with Elie Chaillot, President & CEO of GE HealthCare International and Irawati Setiady, President Director of Kalbe.
This pioneering production facility is the result of a strategic collaboration between Kalbe Farma’s subsidiary Forsta and GE HealthCare. It marks a major advancement in the country’s ambition to build a resilient, self-reliant healthcare system—by accelerating access to medical imaging technology and developing local manufacturing expertise.
“This facility will help us respond faster to local needs while maintaining the highest international standards of quality and safety,” said Elie Chaillot. “This production facility improves access to critical advanced diagnostic technology, creates high value jobs and supports the development of Indonesia’s health technology workforce.”
With a population of over 280 million spread across thousands of islands, Indonesia faces unique challenges in healthcare access. By establishing local production, Kalbe and GE HealthCare aim to reduce reliance on imports, cut delivery times, and make life-saving diagnostic tools more accessible to hospitals and clinics nationwide.
“The strategic partnership between Kalbe and GE HealthCare to supply CT scan machines locally exemplifies Kalbe’s commitment to government efforts focused on supporting national health resilience and local health industry self-sufficiency. We hope that by producing the CT Scan machines domestically will also enhance healthcare services and improving the quality of life for the Indonesian population,” stated Irawati.
CT scan is a widely used health diagnostic tool known for its detailed capabilities in identifying various diseases. “The establishment of CT scan machines local production is among the top ten health devices prioritized for local production. Therefore, establishing a domestic CT scan production facility is crucial for enhancing access to broader healthcare services. Forsta is proud to play a role in strengthening Indonesia’s ability to meet its own healthcare needs,” stated Yvone Astri Della Sijabat, Director of Forsta.
The new production facility is also expected to create employment opportunities, supporting the growth of Indonesia’s health technology workforce and enabling knowledge transfer in advanced medical manufacturing.
CT scanners are among the ten medical devices prioritized by the Indonesian government for domestic production. This investment supports that policy while laying the foundation for future innovation and greater healthcare independence.
